The immunohistochemical analysis showed that ACY1 combined with sequestosome-1 and glypican-3 represents a potentially valuable biomarker for distinguishing between well-differentiated HCC and high-grade dysplastic nodules (31). The gene discussed is GPC3; the disease is hepatocellular carcinoma.